{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:57:50Z","timestamp":1784807870635,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873784"],"award-info":[{"award-number":["81873784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009399","name":"Peking University Third Hospital","doi-asserted-by":"publisher","award":["BYSYDL2019002"],"award-info":[{"award-number":["BYSYDL2019002"]}],"id":[{"id":"10.13039\/501100009399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79910-1","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T07:55:47Z","timestamp":1731743747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lower creatinine-to-cystatin c ratio associated with increased risk of incident amyotrophic lateral sclerosis in the prospective UK biobank cohort"],"prefix":"10.1038","volume":"14","author":[{"given":"Zhuoya","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"79910_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/s0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman, E. L. et al. Amyotrophic lateral sclerosis. Lancet 400, 1363\u20131380. https:\/\/doi.org\/10.1016\/s0140-6736(22)01272-7 (2022).","journal-title":"Lancet"},{"key":"79910_CR2","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1007\/s00415-022-11268-8","volume":"269","author":"J Yang","year":"2022","unstructured":"Yang, J., Jiang, F., Yang, M. & Chen, Z. Sarcopenia and nervous system disorders. J Neurol 269, 5787\u20135797. https:\/\/doi.org\/10.1007\/s00415-022-11268-8 (2022).","journal-title":"J Neurol"},{"key":"79910_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/jnnp-2017-317077","volume":"89","author":"RPA van Eijk","year":"2018","unstructured":"van Eijk, R. P. A. et al. Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials. J Neurol Neurosurg Psychiatry 89, 156\u2013161. https:\/\/doi.org\/10.1136\/jnnp-2017-317077 (2018).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"79910_CR4","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1007\/s00415-019-09507-6","volume":"266","author":"D Ito","year":"2019","unstructured":"Ito, D. et al. Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis. J Neurol 266, 2952\u20132961. https:\/\/doi.org\/10.1007\/s00415-019-09507-6 (2019).","journal-title":"J Neurol"},{"key":"79910_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown, R. H. & Al-Chalabi, A. Amyotrophic lateral sclerosis. N Engl J Med 377, 162\u2013172. https:\/\/doi.org\/10.1056\/NEJMra1603471 (2017).","journal-title":"N Engl J Med"},{"key":"79910_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000518908","volume":"77","author":"M Kurihara","year":"2021","unstructured":"Kurihara, M. et al. Factors affecting energy metabolism and prognosis in patients with amyotrophic lateral sclerosis. Ann Nutr Metab 77, 236\u2013243. https:\/\/doi.org\/10.1159\/000518908 (2021).","journal-title":"Ann Nutr Metab"},{"key":"79910_CR7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1080\/01616412.2022.2096004","volume":"44","author":"C Vinciguerra","year":"2022","unstructured":"Vinciguerra, C. et al. Temporal muscle thickness and survival in patients with amyotrophic lateral sclerosis. Neurol Res 44, 1006\u20131010. https:\/\/doi.org\/10.1080\/01616412.2022.2096004 (2022).","journal-title":"Neurol Res"},{"key":"79910_CR8","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1111\/ene.15003","volume":"28","author":"CJ Holdom","year":"2021","unstructured":"Holdom, C. J. et al. Venous creatinine as a biomarker for loss of fat-free mass and disease progression in patients with amyotrophic lateral sclerosis. Eur J Neurol 28, 3615\u20133625. https:\/\/doi.org\/10.1111\/ene.15003 (2021).","journal-title":"Eur J Neurol"},{"key":"79910_CR9","doi-asserted-by":"publisher","unstructured":"Scaricamazza, S., Salvatori, I., Ferri, A. & Valle, C. Skeletal muscle in ALS: An unappreciated therapeutic opportunity? Cells 10, https:\/\/doi.org\/10.3390\/cells10030525 (2021).","DOI":"10.3390\/cells10030525"},{"key":"79910_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s00415-017-8719-1","volume":"265","author":"M \u00c5berg","year":"2018","unstructured":"\u00c5berg, M. et al. Risk factors in Swedish young men for amyotrophic lateral sclerosis in adulthood. J Neurol 265, 460\u2013470. https:\/\/doi.org\/10.1007\/s00415-017-8719-1 (2018).","journal-title":"J Neurol"},{"key":"79910_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40035-022-00331-z","volume":"11","author":"S L\u00e9pine","year":"2022","unstructured":"L\u00e9pine, S., Castellanos-Montiel, M. J. & Durcan, T. M. TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis. Transl Neurodegener 11, 56. https:\/\/doi.org\/10.1186\/s40035-022-00331-z (2022).","journal-title":"Transl Neurodegener"},{"key":"79910_CR12","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/s0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft, A. J. & Sayer, A. A. Sarcopenia. Lancet 393, 2636\u20132646. https:\/\/doi.org\/10.1016\/s0140-6736(19)31138-9 (2019).","journal-title":"Lancet"},{"key":"79910_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00223-013-9757-z","volume":"93","author":"C Cooper","year":"2013","unstructured":"Cooper, C. et al. Tools in the assessment of sarcopenia. Calcif Tissue Int 93, 201\u2013210. https:\/\/doi.org\/10.1007\/s00223-013-9757-z (2013).","journal-title":"Calcif Tissue Int"},{"key":"79910_CR14","doi-asserted-by":"publisher","first-page":"O20","DOI":"10.1111\/codi.12805","volume":"17","author":"KI Jones","year":"2015","unstructured":"Jones, K. I., Doleman, B., Scott, S., Lund, J. N. & Williams, J. P. Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Colorectal Dis 17, O20-26. https:\/\/doi.org\/10.1111\/codi.12805 (2015).","journal-title":"Colorectal Dis"},{"key":"79910_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12877-022-02925-8","volume":"22","author":"C Zheng","year":"2022","unstructured":"Zheng, C. et al. Serum creatinine\/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer. BMC Geriatr 22, 207. https:\/\/doi.org\/10.1186\/s12877-022-02925-8 (2022).","journal-title":"BMC Geriatr"},{"key":"79910_CR16","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/ccm.0000000000002013","volume":"45","author":"KB Kashani","year":"2017","unstructured":"Kashani, K. B. et al. Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index. Crit Care Med 45, e23\u2013e29. https:\/\/doi.org\/10.1097\/ccm.0000000000002013 (2017).","journal-title":"Crit Care Med"},{"key":"79910_CR17","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.clnu.2020.08.010","volume":"40","author":"K Hirai","year":"2021","unstructured":"Hirai, K. et al. Serum creatinine\/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease. Clin Nutr 40, 1274\u20131280. https:\/\/doi.org\/10.1016\/j.clnu.2020.08.010 (2021).","journal-title":"Clin Nutr"},{"key":"79910_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.diabres.2018.02.025","volume":"139","author":"T Osaka","year":"2018","unstructured":"Osaka, T. et al. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes. Diabetes Res Clin Pract 139, 52\u201358. https:\/\/doi.org\/10.1016\/j.diabres.2018.02.025 (2018).","journal-title":"Diabetes Res Clin Pract"},{"key":"79910_CR19","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/jcsm.12977","volume":"13","author":"T Tang","year":"2022","unstructured":"Tang, T. et al. Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer. J Cachexia Sarcopenia Muscle 13, 1800\u20131810. https:\/\/doi.org\/10.1002\/jcsm.12977 (2022).","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"79910_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jad.2022.09.030","volume":"319","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. Sex differences in the relationship of serum creatinine to cystatin C ratio and depressive symptoms among middle-aged and older adults in China. J Affect Disord 319, 57\u201361. https:\/\/doi.org\/10.1016\/j.jad.2022.09.030 (2022).","journal-title":"J Affect Disord"},{"key":"79910_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ncn3.11","volume":"1","author":"S Tetsuka","year":"2013","unstructured":"Tetsuka, S., Morita, M., Ikeguchi, K. & Nakano, I. Creatinine\/cystatin C ratio as a surrogate marker of residual muscle mass in amyotrophic lateral sclerosis. Neurol. Clin. Neurosci. 1, 32\u201337 (2013).","journal-title":"Neurol. Clin. Neurosci."},{"key":"79910_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3904\/kjim.2016.015","volume":"31","author":"KM Kim","year":"2016","unstructured":"Kim, K. M., Jang, H. C. & Lim, S. Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med 31, 643\u2013650. https:\/\/doi.org\/10.3904\/kjim.2016.015 (2016).","journal-title":"Korean J Intern Med"},{"key":"79910_CR23","doi-asserted-by":"publisher","first-page":"1122922","DOI":"10.3389\/fpubh.2023.1122922","volume":"11","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Sarcopenia index based on serum creatinine and cystatin C is associated with mortality in middle-aged and older adults in Chinese: A retrospective cohort study from the China Health and Retirement Longitudinal Study. Front Public Health 11, 1122922. https:\/\/doi.org\/10.3389\/fpubh.2023.1122922 (2023).","journal-title":"Front Public Health"},{"key":"79910_CR24","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12, e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779 (2015).","journal-title":"PLoS Med"},{"key":"79910_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/cen.14990","volume":"100","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross-sectional and prospective study of 368,634 UK Biobank participants. Clin Endocrinol (Oxf) 100, 116\u2013123. https:\/\/doi.org\/10.1111\/cen.14990 (2024).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"79910_CR26","doi-asserted-by":"publisher","first-page":"111821","DOI":"10.1016\/j.mad.2023.111821","volume":"212","author":"A Nicoletti","year":"2023","unstructured":"Nicoletti, A. et al. Sex and gender differences in Alzheimer\u2019s disease, Parkinson\u2019s disease, and Amyotrophic Lateral Sclerosis: A narrative review. Mech Ageing Dev 212, 111821. https:\/\/doi.org\/10.1016\/j.mad.2023.111821 (2023).","journal-title":"Mech Ageing Dev"},{"key":"79910_CR27","doi-asserted-by":"publisher","first-page":"664100","DOI":"10.3389\/fphys.2021.664100","volume":"12","author":"S Li","year":"2021","unstructured":"Li, S. et al. Serum creatinine-to-cystatin C ratio in the progression monitoring of non-alcoholic fatty liver disease. Front Physiol 12, 664100. https:\/\/doi.org\/10.3389\/fphys.2021.664100 (2021).","journal-title":"Front Physiol"},{"key":"79910_CR28","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1038\/s41598-022-06463-6","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Tang, L., Huang, T. & Fan, D. Association between type 2 diabetes and amyotrophic lateral sclerosis. Sci Rep 12, 2544. https:\/\/doi.org\/10.1038\/s41598-022-06463-6 (2022).","journal-title":"Sci Rep"},{"key":"79910_CR29","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ana.24936","volume":"81","author":"D Mariosa","year":"2017","unstructured":"Mariosa, D. et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol 81, 718\u2013728. https:\/\/doi.org\/10.1002\/ana.24936 (2017).","journal-title":"Ann Neurol"},{"key":"79910_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/ene.15584","volume":"30","author":"K Xia","year":"2023","unstructured":"Xia, K. et al. Mutation-specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis. Eur J Neurol 30, 87\u201395. https:\/\/doi.org\/10.1111\/ene.15584 (2023).","journal-title":"Eur J Neurol"},{"key":"79910_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbi.2023.07.026","volume":"114","author":"GD Batty","year":"2023","unstructured":"Batty, G. D., Kivim\u00e4ki, M., Frank, P., Gale, C. R. & Wright, L. Systemic inflammation and subsequent risk of amyotrophic lateral sclerosis: Prospective cohort study. Brain Behav Immun 114, 46\u201351. https:\/\/doi.org\/10.1016\/j.bbi.2023.07.026 (2023).","journal-title":"Brain Behav Immun"},{"key":"79910_CR32","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jamaneurol.2016.6179","volume":"74","author":"C Lunetta","year":"2017","unstructured":"Lunetta, C. et al. Serum C-reactive protein as a prognostic biomarker in amyotrophic lateral sclerosis. JAMA Neurol 74, 660\u2013667. https:\/\/doi.org\/10.1001\/jamaneurol.2016.6179 (2017).","journal-title":"JAMA Neurol"},{"key":"79910_CR33","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1111\/ene.14409","volume":"27","author":"J Sun","year":"2020","unstructured":"Sun, J. et al. Blood biomarkers and prognosis of amyotrophic lateral sclerosis. Eur J Neurol 27, 2125\u20132133. https:\/\/doi.org\/10.1111\/ene.14409 (2020).","journal-title":"Eur J Neurol"},{"key":"79910_CR34","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1007\/s00415-021-10564-z","volume":"268","author":"G Zhang","year":"2021","unstructured":"Zhang, G. et al. Daytime sleepiness might increase the risk of ALS: A 2-sample Mendelian randomization study. J Neurol 268, 4332\u20134339. https:\/\/doi.org\/10.1007\/s00415-021-10564-z (2021).","journal-title":"J Neurol"},{"key":"79910_CR35","doi-asserted-by":"publisher","first-page":"e0148495","DOI":"10.1371\/journal.pone.0148495","volume":"11","author":"SW Kim","year":"2016","unstructured":"Kim, S. W. et al. A new equation to estimate muscle mass from creatinine and cystatin C. PLoS One 11, e0148495. https:\/\/doi.org\/10.1371\/journal.pone.0148495 (2016).","journal-title":"PLoS One"},{"key":"79910_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0300060515579116","volume":"43","author":"K Suzuki","year":"2015","unstructured":"Suzuki, K. et al. Utility of creatinine\/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study. J Int Med Res 43, 573\u2013582. https:\/\/doi.org\/10.1177\/0300060515579116 (2015).","journal-title":"J Int Med Res"},{"key":"79910_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2015.06.002","volume":"24","author":"FB Sime","year":"2015","unstructured":"Sime, F. B., Udy, A. A. & Roberts, J. A. Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization. Curr Opin Pharmacol 24, 1\u20136. https:\/\/doi.org\/10.1016\/j.coph.2015.06.002 (2015).","journal-title":"Curr Opin Pharmacol"},{"key":"79910_CR38","doi-asserted-by":"publisher","first-page":"E305","DOI":"10.21037\/jtd.2016.03.62","volume":"8","author":"C Thongprayoon","year":"2016","unstructured":"Thongprayoon, C., Cheungpasitporn, W. & Kashani, K. Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients. J Thorac Dis 8, E305-311. https:\/\/doi.org\/10.21037\/jtd.2016.03.62 (2016).","journal-title":"J Thorac Dis"},{"key":"79910_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1515\/cclm.1999.064","volume":"37","author":"E Randers","year":"1999","unstructured":"Randers, E. & Erlandsen, E. J. Serum cystatin C as an endogenous marker of the renal function\u2013a review. Clin Chem Lab Med 37, 389\u2013395. https:\/\/doi.org\/10.1515\/cclm.1999.064 (1999).","journal-title":"Clin Chem Lab Med"},{"key":"79910_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/6568","volume":"5","author":"P Klivenyi","year":"1999","unstructured":"Klivenyi, P. et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5, 347\u2013350. https:\/\/doi.org\/10.1038\/6568 (1999).","journal-title":"Nat Med"},{"key":"79910_CR41","doi-asserted-by":"publisher","first-page":"e37258","DOI":"10.1371\/journal.pone.0037258","volume":"7","author":"YE Yoo","year":"2012","unstructured":"Yoo, Y. E. & Ko, C. P. Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice. PLoS One 7, e37258. https:\/\/doi.org\/10.1371\/journal.pone.0037258 (2012).","journal-title":"PLoS One"},{"key":"79910_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.nbd.2006.05.009","volume":"23","author":"EL Holzbaur","year":"2006","unstructured":"Holzbaur, E. L. et al. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol Dis 23, 697\u2013707. https:\/\/doi.org\/10.1016\/j.nbd.2006.05.009 (2006).","journal-title":"Neurobiol Dis"},{"key":"79910_CR43","doi-asserted-by":"publisher","first-page":"e424","DOI":"10.1212\/wnl.0000000000007861","volume":"93","author":"O Nakken","year":"2019","unstructured":"Nakken, O., Meyer, H. E., Stigum, H. & Holm\u00f8y, T. High BMI is associated with low ALS risk: A population-based study. Neurology 93, e424\u2013e432. https:\/\/doi.org\/10.1212\/wnl.0000000000007861 (2019).","journal-title":"Neurology"},{"key":"79910_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3389\/fneur.2019.00783","volume":"10","author":"S Tsitkanou","year":"2019","unstructured":"Tsitkanou, S., Della Gatta, P., Foletta, V. & Russell, A. The role of exercise as a non-pharmacological therapeutic approach for amyotrophic lateral sclerosis: Beneficial or detrimental?. Front Neurol 10, 783. https:\/\/doi.org\/10.3389\/fneur.2019.00783 (2019).","journal-title":"Front Neurol"},{"key":"79910_CR45","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.apmr.2010.08.009","volume":"91","author":"M Sanjak","year":"2010","unstructured":"Sanjak, M., Bravver, E., Bockenek, W. L., Norton, H. J. & Brooks, B. R. Supported treadmill ambulation for amyotrophic lateral sclerosis: A pilot study. Arch Phys Med Rehabil 91, 1920\u20131929. https:\/\/doi.org\/10.1016\/j.apmr.2010.08.009 (2010).","journal-title":"Arch Phys Med Rehabil"},{"key":"79910_CR46","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1212\/01.wnl.0000264418.92308.a4","volume":"68","author":"VD Bello-Haas","year":"2007","unstructured":"Bello-Haas, V. D. et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 68, 2003\u20132007. https:\/\/doi.org\/10.1212\/01.wnl.0000264418.92308.a4 (2007).","journal-title":"Neurology"},{"key":"79910_CR47","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00726-011-0851-0","volume":"40","author":"MF Beal","year":"2011","unstructured":"Beal, M. F. Neuroprotective effects of creatine. Amino Acids 40, 1305\u20131313. https:\/\/doi.org\/10.1007\/s00726-011-0851-0 (2011).","journal-title":"Amino Acids"},{"key":"79910_CR48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","volume":"97","author":"M Cozzolino","year":"2012","unstructured":"Cozzolino, M. & Carr\u00ec, M. T. Mitochondrial dysfunction in ALS. Prog Neurobiol 97, 54\u201366. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.06.003 (2012).","journal-title":"Prog Neurobiol"},{"key":"79910_CR49","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1007\/s00421-012-2378-9","volume":"112","author":"L Guimar\u00e3es-Ferreira","year":"2012","unstructured":"Guimar\u00e3es-Ferreira, L. et al. Short-term creatine supplementation decreases reactive oxygen species content with no changes in expression and activity of antioxidant enzymes in skeletal muscle. Eur J Appl Physiol 112, 3905\u20133911. https:\/\/doi.org\/10.1007\/s00421-012-2378-9 (2012).","journal-title":"Eur J Appl Physiol"},{"key":"79910_CR50","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.freeradbiomed.2005.10.035","volume":"40","author":"P Sestili","year":"2006","unstructured":"Sestili, P. et al. Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. Free Radic Biol Med 40, 837\u2013849. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.10.035 (2006).","journal-title":"Free Radic Biol Med"},{"key":"79910_CR51","doi-asserted-by":"publisher","unstructured":"Lepore, E., Casola, I., Dobrowolny, G. & Musar\u00f2, A. Neuromuscular junction as an entity of nerve-muscle communication. Cells 8, https:\/\/doi.org\/10.3390\/cells8080906 (2019).","DOI":"10.3390\/cells8080906"},{"key":"79910_CR52","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1002\/cphy.c100087","volume":"2","author":"CJ Heckman","year":"2012","unstructured":"Heckman, C. J. & Enoka, R. M. Motor unit. Compr Physiol 2, 2629\u20132682. https:\/\/doi.org\/10.1002\/cphy.c100087 (2012).","journal-title":"Compr Physiol"},{"key":"79910_CR53","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12031-010-9467-1","volume":"43","author":"M Dadon-Nachum","year":"2011","unstructured":"Dadon-Nachum, M., Melamed, E. & Offen, D. The, \u201cdying-back\u201d phenomenon of motor neurons in ALS. J Mol Neurosci 43, 470\u2013477. https:\/\/doi.org\/10.1007\/s12031-010-9467-1 (2011).","journal-title":"J Mol Neurosci"},{"key":"79910_CR54","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/jcsm.12945","volume":"13","author":"L Le Gall","year":"2022","unstructured":"Le Gall, L. et al. Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles. J Cachexia Sarcopenia Muscle 13, 1385\u20131402. https:\/\/doi.org\/10.1002\/jcsm.12945 (2022).","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"79910_CR55","doi-asserted-by":"publisher","first-page":"155557","DOI":"10.1016\/j.metabol.2023.155557","volume":"144","author":"HN Jung","year":"2023","unstructured":"Jung, H. N., Jung, C. H. & Hwang, Y. C. Sarcopenia in youth. Metabolism 144, 155557. https:\/\/doi.org\/10.1016\/j.metabol.2023.155557 (2023).","journal-title":"Metabolism"},{"key":"79910_CR56","doi-asserted-by":"publisher","unstructured":"Quessada, C. et al. Skeletal muscle metabolism: Origin or prognostic factor for amyotrophic lateral sclerosis (ALS) development? Cells 10, https:\/\/doi.org\/10.3390\/cells10061449 (2021).","DOI":"10.3390\/cells10061449"},{"key":"79910_CR57","doi-asserted-by":"publisher","unstructured":"Ghasemzadeh, N., Nyberg, F. & Hjert\u00e9n, S. Highly selective artificial gel antibodies for detection and quantification of biomarkers in clinical samples. II. Albumin in body fluids of patients with neurological disorders. J Sep Sci 31, 3954\u20133958, https:\/\/doi.org\/10.1002\/jssc.200800386 (2008).","DOI":"10.1002\/jssc.200800386"},{"key":"79910_CR58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3988\/jcn.2013.9.2.125","volume":"9","author":"JW Yang","year":"2013","unstructured":"Yang, J. W. et al. Hypolipidemia in patients with amyotrophic lateral sclerosis: A possible gender difference?. J Clin Neurol 9, 125\u2013129. https:\/\/doi.org\/10.3988\/jcn.2013.9.2.125 (2013).","journal-title":"J Clin Neurol"},{"key":"79910_CR59","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaneurol.2014.1129","volume":"71","author":"A Chi\u00f2","year":"2014","unstructured":"Chi\u00f2, A. et al. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. JAMA Neurol 71, 1134\u20131142. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1129 (2014).","journal-title":"JAMA Neurol"},{"key":"79910_CR60","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/jnnp-2018-318810","volume":"89","author":"S Liu","year":"2018","unstructured":"Liu, S. et al. Excessive daytime sleepiness in Chinese patients with sporadic amyotrophic lateral sclerosis and its association with cognitive and behavioural impairments. J Neurol Neurosurg Psychiatry 89, 1038\u20131043. https:\/\/doi.org\/10.1136\/jnnp-2018-318810 (2018).","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79910-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79910-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79910-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T08:03:56Z","timestamp":1731744236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79910-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79910"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79910-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical declarations"}}],"article-number":"28289"}}